Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 EUR | 0.00% | +2.20% | +19.23% |
Apr. 22 | Cellularline buys 7,000 of its own ordinary shares | AN |
Apr. 15 | Cellularline updates on its buyback program | AN |
Strengths
- The stock, which is currently worth 2024 to 0.53 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
Ratings chart - Surperformance
Sector: Computer & Electronics Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.23% | 63.18M | - | ||
-18.91% | 1.25B | B- | ||
-15.30% | 1.14B | - | ||
-6.57% | 391M | - | ||
-0.63% | 313M | - | - | |
+2.06% | 218M | - | ||
0.00% | 205M | - | - | |
+17.67% | 92.98M | - | - | |
-9.72% | 64.32M | - | - | |
+12.19% | 60.28M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CELL Stock
- Ratings Cellularline S.p.A.